PROTEOMICS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PROTEOMICS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jongmans who started this subject	5/23/2003 12:03:55 PM
From: nigel bates	of 539

GeneProt Licenses Its First Protein to Novartis GENEVA, May 23 /PRNewswire/ -- GeneProt Inc. today announced that Novartis Pharma AG (Basel, Switzerland) has licensed one of GeneProt's proteins. "This is the first protein to be licensed under our Strategic Collaboration with Novartis. We look forward to further licenses in due course coming out of our collaboration with Novartis and from others," said Bertrand Damour, GeneProt's President and CEO. "This protein is one of more than 20 proteins and polypeptides that are being studied at Novartis and elsewhere. Our chemical synthesis approach enables us to rapidly provide samples in the quantities and purity required for pre-clinical studies," said Keith Rose, GeneProt's CSO. Financial terms were not disclosed...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next